rs1921
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_005101.4(ISG15):c.248G>A(p.Ser83Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 1,613,414 control chromosomes in the GnomAD database, including 120,507 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ISG15 | NM_005101.4 | c.248G>A | p.Ser83Asn | missense_variant | 2/2 | ENST00000649529.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ISG15 | ENST00000649529.1 | c.248G>A | p.Ser83Asn | missense_variant | 2/2 | NM_005101.4 | P1 | ||
ISG15 | ENST00000624697.4 | c.224G>A | p.Ser75Asn | missense_variant | 3/3 | 3 | |||
ISG15 | ENST00000624652.1 | c.224G>A | p.Ser75Asn | missense_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.384 AC: 58370AN: 152098Hom.: 11551 Cov.: 35
GnomAD3 exomes AF: 0.359 AC: 89869AN: 250098Hom.: 17226 AF XY: 0.362 AC XY: 49094AN XY: 135512
GnomAD4 exome AF: 0.383 AC: 559161AN: 1461196Hom.: 108952 Cov.: 74 AF XY: 0.382 AC XY: 277736AN XY: 726914
GnomAD4 genome AF: 0.384 AC: 58393AN: 152218Hom.: 11555 Cov.: 35 AF XY: 0.383 AC XY: 28525AN XY: 74422
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 49% of patients studied by a panel of primary immunodeficiencies. Number of patients: 47. Only high quality variants are reported. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
not provided Benign:1Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at